Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Different diseases cause specific skin and hair follicle changes in dogs with alopecia.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Alopecia areata causes unpredictable hair loss and requires personalized treatment.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Accurate fungal identification is crucial for proper treatment in immunocompromised patients.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Trichodysplasia spinulosa is a rare skin condition linked to weakened immune systems, mostly in organ transplant patients.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Current models for studying alopecia are inadequate, and more human-like systems are needed.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

The nail matrix has a reduced immune response, protecting it from autoimmunity.